Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9160bb096a5c59c98f242f587e537811 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
filingDate |
2001-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aae5a2d015a95903dc395d0555dea97c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4317402186e691b7ba6c676842e63981 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4bcc0add13de6379981fac68693909ff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b215606dc4be6808d6d43e656f23b5f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d982592f350cf465d1c3ca2ec826fb1b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f95563beadd4b638d13d63272cdeda6 |
publicationDate |
2003-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
HU-0300900-A2 |
titleOfInvention |
Polymorphs of N- [4- (3-chloro-4-fluorophenylamino) -7- (3-morpholin-4-yl-propoxy) -quinazolin-6-yl] -acrylamide dihydrochloride; and their use |
abstract |
This invention relates to N- [4- (3-chloro-4-fluoro-phenylamino) -7- (3-morpholin-4-yl-propoxy) -quinazolin-6-yl] -acrylamide of formula (I). polymorphic forms of the dihydrochloride are processes for their preparation and their use in the preparation of medicaments with irreversible tyrosine kinase inhibitors. SHE |
priorityDate |
2000-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |